Multi-system Supplement

Sulforaphane (glucoraphanin + active myrosinase)

form-specific Grade and summary pending review Evidence Grade Strength of published clinical evidence — not a safety rating or a recommendation. How to read this

Dimension Scores

Human Outcome

•

Biomarker Relevance

•

Signal Source Quality

•

Organ Specificity

•

Interaction Certainty

•

Translational Maturity

•

Per-dimension evidence strength is part of the full analysis Unlock full analysis

No indication-level signals recorded yet. The grade above has not been decomposed, so it should be read as a whole-compound assessment rather than a claim about any one indication.

Evidence Summary

Glucoraphanin delivered together with active myrosinase converts to sulforaphane during digestion. Conversion is more reliable than precursor alone but still less predictable than taking the preformed compound, and human data does not go beyond biomarker endpoints; no clinical outcomes have been measured. This is graded as a separate entry because the exposure achieved differs from the other forms.

Evidence Signals (0)

🔒

Create a free account to see signal-level evidence grades.

Create a free account

Products Containing Sulforaphane (glucoraphanin + active myrosinase)

No commercial products are currently listed for this molecule.

This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.